On the Road to Recovery After Critical Illness
ORRCI
Feasibility of a Comprehensive Driving Assessment to Inform Driving Resumption Following Critical Illness: an Interventional Cohort Study
1 other identifier
interventional
80
1 country
1
Brief Summary
Spending time on intensive care can affect people in many different ways. Ability to move, walk, concentrate and remember events can all be affected. People may find their mood is altered and anxiety, stress and reduced confidence are common. These symptoms are frequently grouped together in a term called 'post intensive care syndrome'. Recovery often takes time and can be challenging. Returning to driving is an important milestone and can enable individuals to return to important activities such as work and hobbies. As a complex task, driving requires individuals to do many things at once which initially can be demanding. Currently there is limited guidance about driving after a period of time on intensive care. This study is being carried out to increase understanding of driving difficulties after a stay on intensive care and how successful and safe return to driving can be ensured. It is known that a stay on intensive care can have many effects on the body but currently the best advice to give to patients about returning to drive is unknown. The investigators would like to gather information on how many people do and do not return to driving and the reasons for this so people can be provided with more accurate information in the future. Additionally, it is important to find out if the driving assessment is practical and achievable for individuals who have had a stay on intensive care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 17, 2020
CompletedStudy Start
First participant enrolled
February 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedJune 4, 2021
June 1, 2021
2.7 years
February 4, 2020
June 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of new driving impairments as determined by a DVLA approved driving assessment
DVLA approved driving assessment will be completed 2 months after discharge from hospital.
2 months
Secondary Outcomes (5)
Patient-reported driving status
3, 6 and 12 month time-ponts
To evaluate acceptability of the driving assessment
2, 3, 6 and 12 month time-points
To evaluate feasibility of the driving assessment
2, 3, 6 and 12 month time-points
Enablers of driving resumption
2, 3, 6 and 12 month time-points
Barriers to driving resumption
2, 3, 6 and 12 month time-points
Study Arms (1)
Interventional
EXPERIMENTALDriving Assessment
Interventions
Participants will undergo a driving assessment approximately two months after returning home from hospital
Eligibility Criteria
You may qualify if:
- Adult \>18 years
- Severe critical illness and high risk PICS as defined by 72 hours or more of invasive mechanical ventilation in ICU
- Previously driving car in the 12 months prior to admission and currently holds UK category B driving licence (i.e.: car category)
- Able and willing to travel to Carshalton, Surrey and undergo full driving ability assessment and study follow up for a duration of 12 months
- Intention to resume driving, or has already resumed driving
You may not qualify if:
- DVLA-confirmed long term driving ineligibility (as per existing DVLA medical guidance)
- Invalid, revoked or expired driving licence
- Deemed unlikely to return to independent living status due to e.g.: severe neurological injury, advanced cancer, progressive/degenerative condition, or other
- High risk of illness recurrence or readmission to hospital
- Social or neuropsychiatric circumstances deemed likely to adversely study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guys and St Thomas NHS Foundation Trust
London, SE1 9RT, United Kingdom
Related Publications (1)
Apps C, Brooks K, Rose L, Meyer J, Pattison N. "Back on the road": Exploring experiences of driving resumption in patients recovering from critical illness. Aust Crit Care. 2025 Nov;38(6):101442. doi: 10.1016/j.aucc.2025.101442. Epub 2025 Oct 24.
PMID: 41138521DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Joel Meyer, MD
Guy's and St Thomas' NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 17, 2020
Study Start
February 26, 2020
Primary Completion
November 1, 2022
Study Completion
February 1, 2023
Last Updated
June 4, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share